Clinical trials
Completed Carcinoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Pfizer | 4 |
| Bayer | 2 |
| Hoffmann-La Roche | 2 |
| Sanofi | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Ariad Pharmaceuticals | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 36 |
| Neoplasms | 14 |
| Adenocarcinoma | 7 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 7 |
| Carcinoma, Hepatocellular | 5 |
| Neuroendocrine Tumors | 5 |
| Neoplasm Metastasis | 4 |
| Neoplasms by Site | 4 |
| Lung Diseases | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.